| 前收盘价格 | 5.44 |
| 收盘价格 | 5.38 |
| 成交量 | 560,790 |
| 平均成交量 (3个月) | 1,179,146 |
| 市值 | 1,216,984,448 |
| 市盈率 (P/E TTM) | 5.81 |
| 预期市盈率 (P/E Forward) | 5.24 |
| 价格/销量 (P/S) | 2.02 |
| 股市价格/股市净资产 (P/B) | 1.63 |
| 52周波幅 | |
| 利润日期 | 13 Aug 2025 - 18 Aug 2025 |
| 营业毛利率 | 34.50% |
| 营业利益率 (TTM) | -6,128.33% |
| 稀释每股收益 (EPS TTM) | 0.930 |
| 季度收入增长率 (YOY) | -92.80% |
| 总债务/股东权益 (D/E MRQ) | 5.78% |
| 流动比率 (MRQ) | 7.65 |
| 营业现金流 (OCF TTM) | 157.03 M |
| 杠杆自由现金流 (LFCF TTM) | 92.39 M |
| 资产报酬率 (ROA TTM) | 19.92% |
| 股东权益报酬率 (ROE TTM) | 33.04% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | CureVac N.V. | 看跌 | 看涨 |
AIStockmoo 评分
-0.6
| 分析师共识 | -0.5 |
| 内部交易活动 | NA |
| 价格波动 | -5.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 4.0 |
| 平均 | -0.63 |
|
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company’s other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 57.37% |
| 机构持股比例 | 4.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Gates Foundation | 30 Sep 2024 | 1,568,866 |
| Gsa Capital Partners Llp | 31 Mar 2025 | 307,941 |
| Goldman Sachs Group Inc | 31 Mar 2025 | 267,404 |
| Deutsche Bank Ag\ | 31 Mar 2025 | 230,813 |
| Bnp Paribas Financial Markets | 31 Mar 2025 | 224,523 |
| Swiss National Bank | 31 Mar 2025 | 198,547 |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt | 31 Mar 2025 | 173,084 |
| Freestone Capital Holdings, Llc | 31 Mar 2025 | 144,073 |
| Legal & General Group Plc | 31 Mar 2025 | 114,839 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 10.00 (JMP Securities, 85.01%) | 购买 |
| 中 | 5.50 (1.76%) | |
| 低 | 5.00 (Jefferies, -7.49%) | 保留 |
| 平均值 | 6.83 (26.36%) | |
| 总计 | 1 购买, 2 保留 | |
| 平均价格@调整类型 | 5.14 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| UBS | 26 Jun 2025 | 5.50 (1.76%) | 保留 | 5.41 |
| 30 Apr 2025 | 12.00 (122.02%) | 购买 | 3.55 | |
| Jefferies | 13 Jun 2025 | 5.00 (-7.49%) | 保留 | 5.57 |
| JMP Securities | 28 May 2025 | 10.00 (85.01%) | 购买 | 4.44 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合